This $198,565 firm fixed-price delivery order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute, for the synthesis of LAVR-289. The contract is part of the NIH's larger "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. Sri International has a history of providing research, engineering, and technical services to federal agencies including the Department of Health and Human Services, Department of Defense, and NASA through various prime and subcontracts. The work will be performed in West Menlo Park, California and is scheduled for completion by September 14, 2023. No small business or socioeconomic set-aside was used for this award.
Generated 3/24/24, 12:19 AM